King Pharmaceuticals KG International — Total Diversified Reinsurance adverse PPD
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept kg:LiabilityforUnpaidClaimsandClaimsAdjustmentExpensePeriodIncreaseDecreaseNetofCommissionChanges.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's international — total diversified reinsurance adverse ppd.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's international — total diversified reinsurance adverse PPD?
- King Pharmaceuticals (KG) reported international — total diversified reinsurance adverse PPD of $206K in Q4 2025.
- What does international — total diversified reinsurance adverse PPD mean?
- This metric represents the total unfavorable prior period development (PPD) recognized within the diversified reinsurance portfolio for the international segment. It reflects the additional costs incurred when actual claims experience exceeds the initial reserves established in previous reporting periods. Monitoring this figure is essential for assessing the accuracy of long-term actuarial reserving practices and the volatility of underwriting results.